Company Filing History:
Years Active: 2018
Title: The Innovative Mind of Yunil Suh: Pioneering DNA Overhang Control
Introduction
Yunil Suh is an influential inventor based in Daejeon, South Korea, recognized for his cutting-edge contributions to the field of biotechnology. With a focused passion for advancing DNA manipulation techniques, Suh has developed methods that significantly improve the efficiency of genetic engineering processes.
Latest Patents
Suh holds a notable patent titled "Method for controlling length of overhang of double stranded DNA." This innovative invention discloses methods and kits specifically designed for regulating the length of overhangs at the ends of double-stranded DNA based on competitive inhibition. The methods outlined are ligase-independent, offering alternative techniques for joining DNA strands efficiently. By controlling the overhangs of double-stranded DNA, this patent enables effective ligation without traditional ligase enzymes, providing valuable tools for DNA recombinant technology, including cloning of genes, DNA fragments, and PCR products.
Career Highlights
Throughout his career, Yunil Suh has collaborated with a team of talented professionals at Enzynomics Co. Ltd., where he has made significant strides in biotechnological innovations. His work not only enhances scientific understanding but also sets a new standard for practical applications in genetics.
Collaborations
At Enzynomics Co. Ltd., Suh has worked alongside esteemed colleagues Yong Keol Shin and Min Young Lee. Their collaborative efforts have fostered a creative environment that promotes breakthroughs in DNA technology.
Conclusion
Yunil Suh's inventive spirit and dedication to biotechnology are paving the way for future developments in genetic engineering. Through his patent on controlling DNA overhang length, he has contributed invaluable methods that will likely influence numerous applications in molecular biology. His work exemplifies the impact of innovation on science and technology, and his contributions are set to benefit researchers and industries alike.